---
title: 'Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer''s Disease: A Systematic
  Review'
date: '2024-05-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38746639/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240515180808&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: GLP-1 RA therapy did not alter amyloid-β and tau biomarkers
  nor show improvements in cognition but showed potential metabolic and neuroprotective
  ...'
disable_comments: true
---
CONCLUSIONS: GLP-1 RA therapy did not alter amyloid-β and tau biomarkers nor show improvements in cognition but showed potential metabolic and neuroprotective ...